save. rate and reply #$30 in one day. 10. The WallStreetBets Reddit community, which upended the stock market this week with its GameStop campaign, has exploded in popularity, but it's been around since 2012. report. This Day in Historical past: Dec. 3. That’s saying a lot, I understand. Print. That’s the intriguing headline from Eric Fry’s issue of Smart Money earlier this week. That's how early we still are… hide. Get ready for trades to be unwound too. MindMed aims for Nasdaq listing after Compass’ magic mushroom-fuelled IPO. Reddit army took up GME $150 in 1 hour. Antrax Chicken Chaser. PRESS RELEASE PR Newswire . MindMed (OTCQB: MMEDF) is a neuro-pharmaceutical company that has initiated clinical studies to evaluate potential treatments to help patients with ADHD, anxiety, … Oct 27, 2017 4,428 Everywhere and nowhere. Telegram . Must Read. September 21, 2020. There can be no assurance that NASDAQ acceptance will be granted. … Strike. Jazz Pharmaceuticals (NASDAQ:JAZZ) announced it has entered into a definitive agreement to acquire GW Pharmaceuticals (NASDAQ:GWPH) (OTC:GWPRF) … This suggests that the stock has a possible downside of 42.9%. Psychedelic Drug Firm MindMed Applies For Nasdaq Up-Itemizing. Jan 28, 2021 #247 Akainu. The listing of MindMed's shares on NASDAQ will be subject to a number of regulatory requirements, including review of the company and acceptance for listing by NASDAQ. 100% Upvoted. View Profile; View Bullboard History (1002) . no comments yet. Broker dealers and exchanges have rules and bylaws, it's not the wild west. Linkedin. 0 comments. Oct 25, 2017 18,718. Richard Staines . Here's what you should know.More From InvestorPlace Why Everyone Is … Let's ...read more posted February 24, 2021 04:39 pm by licari . MindMed maintains approximately $144.7M in cash on hand. It is possible. I just hope MindMed gets on the Nasdaq before ATAI goes public. NEW YORK, Sept. 21, 2020 -- Mind Medicine (MindMed) Inc. (NEO: MMED)(OTCQB: MMEDF)(DE: MMQ), the leading drug development company for psychedelic inspired medicines, is evaluating an expanded United States investor base through an up-listing on the NASDAQ Capital Market ('NASDAQ').Mindmed logo (PRNewsfoto/Mind Medicine, Inc. (Mindmed))As part of this up-listing strategy in the United … Mind Medicine (MindMed) Inc (NEO:MMED)(OTCQB:MMEDF) CEO JR Rahn the leading drug development company for psychedelic-inspired medicines tells Proactive the group is evaluating an expanded US investor base through an up-listing on the Nasdaq Capital Market. WhatsApp. — Reddit (@reddit) February 8, 2021 Why It Matters: ViacomCBS Inc (NASDAQ: VIAC)-owned CBS sought $5.5 million for a 30-second in-game spot for the Superbowl, according to Variety. As a former market reg officer at the NYSE and NASDAQ this was always coming. MMED | Complete Mind Medicine (MindMed) Inc. stock news by MarketWatch. share. Now it's time for the MMED to take us to $30. Be the first to share what you think! ReddIt. Sort by. Facebook. Member. Otherwise some people might jump ship. It's important to note that there is no psychedelic medicine company in phase 3 yet. Reddit has raised $250 million in a Series E fundraising round, the company announced Monday night. Their forecasts range from $2.00 to $2.00. View analysts' price targets for Mind Medicine (MindMed) or … Be the first to share what you think! 0 comments. On average, they anticipate Mind Medicine (MindMed)'s share price to reach $2.00 in the next twelve months. 12. report. MMEDF stock is on the move today after psychedelics firm MindMed announced a new clinical trial. Police arrest 800 college students on the College of California at Berkeley, at some point after they staged... Read more. best . Politics December 2, 2020 0. Companies like Mind Medicine (MindMed) Inc. (OTCQB: MMEDF), Ehave, Inc. (OTC Pink: EHVVF), COMPASS Pathways plc (NASDAQ:CMPS), and Mydecine Innovations Group (OTC: MYCOF) have significant prospects for future growth. Log in or sign up to leave a comment Log In Sign Up. Qualcomm Incorporated (NASDAQ: QCOM) today announced that its subsidiary, Qualcomm Technologies, Inc., has entered into a definitive agreement to acquire NUVIA for approximately $1.4 billion before working capital and other adjustments. Log in or sign up to leave a comment Log In Sign Up. MindMed has many trials in phases 1 and 2 as we speak. A sudden wave of new users and YOLO stock buying has reshaped the sub's identity. Pinterest. no comments yet. I have read that MindMed applied to be added to the Nasdaq late last year, is there anywhere that I could see where MindMed is currently at in the application process? Member. MindMed is also conducting trials for things like LSD. This progress was enough to attract Canaccord analysts who issued a Buy on the stock. best. 100% Upvoted. STOP THE CLOCK! save. Not sure what else could be holding MindMed up. The New York company has appointed Canaccord Genuity as financial advisor to assess the viability of the up-listing and to help evaluate M&A opportunities Stock analysis for Mind Medicine MindMed Inc (MMED:NEO-L Lit) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The subreddit remained relatively small until 2020, when popularity in stock trading apps soared. MindMed has six medications and treatment protocols currently in clinical trials, including treatments for opioid addiction, depression, anxiety, and headaches. MindMed’s announcement comes just days after U.K.-based Compass Pathways, which has patented a synthetic form of psilocybin for use in treatment-resistant depression, went public on the Nasdaq. posted February 24, 2021 04:02 pm by maysteeler23 . Sort by . 11. View real-time stock prices and stock quotes for a full financial overview. MindMed is a psychedelic medicine biotech company that discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. Even though psychedelic therapies are still in their infancy, I think there are already a few promising Psychedelic Stocks, such as Compass Pathways (NASDAQ: CMPS) and MindMed … share. Share. Stop selling and raise your bids to $30. Email. In an industry-first, the company recently began a clinical trial measuring and evaluating MDMA and LSD’s combination in the human body. September 25, 2020. Even though psychedelic therapies are still in their infancy, I think there are already a few promising Psychedelic Stocks, such as Compass Pathways (NASDAQ: CMPS) and MindMed … MyPillow CEO Mike Lindell says he's losing $65 million over election fraud claims and it proves he's not pushing conspiracy theories for the money You have the POWER! MindMed has at least five known catalysts expected to occur this year, including a Nasdaq listing that is imminent. Easily the riskiest among stocks selling at a discount, psychedelic medicine specialist MindMed nevertheless probably has the highest upside potential. Twitter. 0. MindMed Closes Upsized Financing of CAD $28.75m With Strong Institutional Demand for Psychedelic Medicines . The last price target from the firm came in November at $2. MindMed Streamlines Leadership with Further Emphasis on Integrating Psychedelic Drug Development with Digital Medicines and Therapeutics PRESS RELEASE PR Newswire Feb. 2, 2021, 01:30 PM hide. New York - Nasdaq: DOWN 2.0 percent at 13,070.69 (close) London - FTSE 100: DOWN 1.8 percent at 6,407.46 (close) Frankfurt - DAX 30: DOWN 1.7 percent at 13,432.87 (close) Paris - CAC 40: DOWN 2.0 percent at 5,399.21 (close) EURO STOXX 50: DOWN 2.1 percent at 3,481.44 (close) Tokyo - Nikkei 225: DOWN 1.9 percent at 27,663.39 (close) 2. Oct. 30, 2020, 09:17 AM. Jan 28, 2021 #248 STOP THE CLOCK!